Activation of the mammalian immune system by siRNAs

Nature Biotechnology

Volumn 23, Issue 11, 2005, Pages 1399-1405

  Marques, Joao T ^a   Williams, Bryan R G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNCTIONS; GENES; RNA;

GENE FUNCTION; HUMAN DISEASES;

IMMUNOLOGY;

OLIGODEOXYNUCLEOTIDE DERIVATIVE; RESIQUIMOD; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

CPG ISLAND; CYTOKINE PRODUCTION; DRUG MECHANISM; GENE SILENCING; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOSTIMULATION; INNATE IMMUNITY; MAMMAL; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE;

ANIMALS; CAENORHABDITIS ELEGANS; ENDOSOMES; GENE SILENCING; GENE THERAPY; HUMANS; IMMUNE SYSTEM; MODELS, BIOLOGICAL; RNA INTERFERENCE; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8;

MAMMALIA;

EID: 27944459341     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1161     Document Type: Review

References (75)

1. Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811 (1998).
2. Mello, C.C. & Conte, D. Jr. Revealing the world of RNA interference. Nature 431, 338-342 (2004).
3. Yang, S., Tutton, S., Pierce, E. & Yoon, K. Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol. Cell. Biol. 21, 7807-7816 (2001).
4. Baulcombe, D. RNA silencing in plants. Nature 431, 356-363 (2004).
5. Meister, G. & Tuschl, T. Mechanisms of gene silencing by double-stranded RNA. Nature 431, 343-349 (2004).
6. Elbashir, S.M., Lendeckel, W. & Tuschl, T. RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev. 15, 188-200 (2001).
7. Tomari, Y. & Zamore, P.D. Perspective: machines for RNAi. Genes Dev. 19, 517-529 (2005).
8. Elbashir, S.M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
9. Caplen, N.J., Parrish, S., Imani, F., Fire, A. & Morgan, R. A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA 98, 9742-9747 (2001).
10. Robinson, R. RNAi therapeutics: how likely, how soon? PLoS Biol. 2, E28 (2004).
11. Sioud, M. & Sorensen, D.R. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem. Biophys. Res. Commun. 312, 1220-1225 (2003).
12. Kariko, K., Bhuyan, P., Capodici, J. & Weissman, D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J. Immunol. 172, 6545-6549 (2004).
13. Sledz, C.A. & Williams, B.R. RNA interference in biology and disease. Blood 106, 787-794 (2005).
14. Sledz, C.A., Holko, M., de Veer, M.J., Silverman, R.H. & Williams, B.R. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 834-839 (2003).
15. Kim, D.H. et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22, 321-325 (2004).
16. Persengiev, S.P., Zhu, X. & Green, M.R. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10, 12-18 (2004).
17. Takeda, K. & Akira, S. Toll-like receptors in innate immunity. Int. Immunol. 17, 1-14 (2005).
18. Hornung, V. et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11, 263-270 (2005).
19. Judge, A.D. et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23, 457-462 (2005).
20. Sioud, M. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. 348, 1079-1090 (2005).
21. Heil, F. et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526-1529 (2004).
22. Diebold, S.S., Kaisho, T., Hemmi, H., Akira, S. & Reis e Sousa, C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531 (2004).
23. Hemmi, H. et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3, 196-200 (2002).
24. Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987-995 (2004).
25. Liu, Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275-306 (2005).
26. Verthelyi, D. & Zeuner, R.A. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol. 24, 519-522 (2003).
27. Heil, F. et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur. J. Immunol. 33, 2987-2997 (2003).
28. Ito, T. et al. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 195, 1507-1512 (2002).
29. Rossi, M. & Young, J.W. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J. Immunol. 175, 1373-1381 (2005).
30. Hornung, V. et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531-4537 (2002).
31. Nagase, H. et al. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J. Immunol. 171, 3977-3982 (2003).
32. Hart, O.M., Athie-Morales, V., O'Connor, G.M. & Gardiner, C.M. TLR7/8-Mediated activation of human NK cells results in accessory cell-dependent IFN-γ production. J. Immunol. 175, 1636-1642 (2005).
33. + T cells. J. Immunol. 175, 1551-1557 (2005).
34. Bekeredjian-Ding, I.B. et al. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J. Immunol. 174, 4043-4050 (2005).
35. Kurt-Jones, E. A. et al. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity. J. Endotoxin Res. 10, 419-424 (2004).
36. Roach, J.C. et al. The evolution of vertebrate Toll-like receptors. Proc. Natl. Acad. Sci. USA 102, 9577-9582 (2005).
37. Gorden, K.B. et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J. Immunol. 174, 1259-1268 (2005).
38. +regulatory T cell function. Science 309, 1380-1384 (2005).
39. Verthelyi, D., Ishii, K.J., Gursel, M., Takeshita, F. & Klinman, D.M. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J. Immunol. 166, 2372-2377 (2001).
40. Rutz, M. et al. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur. J. Immunol. 34, 2541-2550 (2004).
41. Honda, K. et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434, 1035-1040 (2005).
42. Soutschek, J. et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432, 173-178 (2004).
43. Heidel, J.D., Hu, S., Liu, X.F., Triche, T.J. & Davis, M.E. Lack of interferon response in animals to naked siRNAs. Nat. Biotechnol. 22, 1579-1582 (2004).
44. Sugiyama, T. et al. CpG RNA: identification of novel single-stranded RNA that stimulates human CD14+CD11c+ monocytes. J. Immunol. 174, 2273-2279 (2005).
45. Choe, J., Kelker, M.S. & Wilson, I.A. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309, 581-585 (2005).
46. Morrissey, D.V. et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23, 1002-1007 (2005).
47. Obika, S. et al. Stability and structural features of the duplexes containing nucleoside analogues with fixed N-type conformation 2′-O, 4′-C. Tetrahedr. Lett. 39, 5401-5404 (1998).
48. Koshkin, A.A. et al. LNA (locked nucleic acid): synthesis of the adenine, cytosine, guanine, 5-methyl cytosine, thymine, and uracil bicyclonucleoside monomers, oligomerisation and unprecedented nucleic acid recognition. Tetrahedron 54, 3607-3630 (1998).
49. Chiu, Y.L. & Rana, T.M. siRNA function in RNAi: a chemical modification analysis. RNA 9, 1034-1048 (2003).
50. Chiu, Y.L. & Rana, T.M. RNAi in human cells: basic structural and functional features of small interfering RNA. Mol. Cell 10, 549-561 (2002).
51. Sen, G. et al. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity. Cell. Immunol. 232, 64-74 (2004).
52. Medzhitov, R. & Janeway, C.A. Jr. Decoding the patterns of self and nonself by the innate immune system. Science 296, 298-300 (2002).
53. Ishii, K.J. & Akira, S. Innate immune recognition of nucleic acids: beyond toll-like receptors. Int. J. Cancer 117, 517-523 (2005).
54. Karlin, S. & Burge, C. Dinucleotide relative abundance extremes: a genomic signature. Trends Genet. 11, 283-290 (1995).
55. Boule, M.W. et al. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199, 1631-1640 (2004).
56. Koski, G.K. et al. Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J. Immunol. 172, 3989-3993 (2004).
57. Scheel, B. et al. Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA. Eur. J. Immunol. 35, 1557-1566 (2005).
58. Kariko, K., Ni, H., Capodici, J., Lamphier, M. & Weissman, D. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 279, 12542-12550 (2004).
59. Kariko, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165-175 (2005).
60. Karlin, S., Doerfler, W. & Cardon, L.R. Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J. Virol. 68, 2889-2897 (1994).
61. Williams, B.R. Signal integration via PKR. Sci. STKE 89, RE2 (2001).
62. Sato, M. et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13, 539-548 (2000).
63. Matsumoto, M. et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171, 3154-3162 (2003).
64. Sha, Q., Truong-Tran, A.Q., Plitt, J.R., Beck, L.A. & Schleimer, R.P. Activation of airway epithelial cells by toll-like receptor agonists. Am. J. Respir. Cell Mol. Biol. 31, 358-364 (2004).
65. Li, K., Chen, Z., Kato, N., Gale, M. Jr. & Lemon, S.M. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J. Biol. Chem. 280, 16739-16747 (2005).
66. Whitmore, M.M. et al. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res. 64, 5850-5860 (2004).
67. Hornung, V. et al. Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J. Immunol. 173, 5935-5943 (2004).
68. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737 (2004).
69. Andrejeva, J. et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. USA 101, 17264-17269 (2004).
70. Kato, H. et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19-28 (2005).
71. Minakuchi, Y. et al. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res. 32, e109 (2004).
72. Kim, V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6, 376-385 (2005).
73. Krieg, A.M. et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549 (1995).
74. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
75. Agrawal, S. & Kandimalla, E.R. Role of Toll-like receptors in antisense and siRNA. Nat. Biotechnol. 22, 1533-1537 (2004).